The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production
@inproceedings{Badiola2013ThePI, title={The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production}, author={Nahuai Badiola and Victor Alcalde and Albert Pujol and Lisa-Marie M{\"u}nter and Gerd Multhaup and Alberto Lle{\'o} and Mireia Coma and Montserrat Soler-Lopez and Patrick Aloy}, booktitle={PloS one}, year={2013} }
A key event in the pathogenesis of Alzheimer's disease (AD) is the accumulation of amyloid-β (Aβ) species in the brain, derived from the sequential cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. Based on a systems biology study to repurpose drugs for AD, we explore the effect of lansoprazole, and other proton-pump inhibitors (PPIs), on Aβ production in AD cellular and animal models. We found that lansoprazole enhances Aβ37, Aβ40 and Aβ42 production and lowers Aβ38… CONTINUE READING
Citations
Publications citing this paper.
SHOWING 1-10 OF 43 CITATIONS
USO DO OMEPRAZOL: ESTUDO DESCRITIVO DE PACIENTES IDOSOS DE UMA UNIDADE DE SAÚDE DA FAMÍLIA (USF) DE RIBEIRÃO PRETO, SP, BRASIL
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
VIEW 3 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED
Risk of dementia in elderly patients with the use of proton pump inhibitors
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED
Proton pump inhibitor use and risk of dementia
VIEW 2 EXCERPTS
CITES BACKGROUND
The Clinician’s Guide to Proton Pump Inhibitor Related Adverse Events
VIEW 1 EXCERPT
CITES BACKGROUND
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
VIEW 1 EXCERPT
CITES BACKGROUND
Association between Proton Pump Inhibitor Use and CNS Infection Risk: A Retrospective Cohort Study
VIEW 2 EXCERPTS
CITES BACKGROUND
References
Publications referenced by this paper.
SHOWING 1-10 OF 53 REFERENCES
Methods and Systems for identifying molecules or processes of biological interest by using knowledge discovery in biological data. Patent
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL
COMMUNICATION Selective inhibition of Ab42 production by NSAID R-enantiomers
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
VIEW 13 EXCERPTS
HIGHLY INFLUENTIAL
Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL
The metalloprotease meprin beta generates amino terminal truncated Abeta-peptide species
VIEW 1 EXCERPT